Skip to main content

Antipodean Advisors LLC

SEC CIK
0001512566
Latest filing
Nov 14, 2023

CDLX holding history

Cardlytics, Inc. in every 13F filed by Antipodean Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CDLX overviewAll 13F holders of CDLXFull Q3 2023 holdings

Shares (Q3 2023)
20,000
Value
$330.0K
% of portfolio
1.7%
Quarters held
11
Since Q1 2021
Holdings of CDLX by Antipodean Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 202320,000$330.0K1.7%−15,000−42.9%ReducedHolders
Q2 202335,000$221.2K1.6%00.0%UnchangedHolders
Q1 202335,000$118.8K0.7%−40,000−53.3%ReducedHolders
Q4 202275,000$433.5K1.4%−465,400−86.1%ReducedHolders
Q3 2022540,400$5.08M13.0%−98,400−15.4%ReducedHolders
Q2 2022638,800$14.3M23.2%00.0%UnchangedHolders
Q1 2022638,800$35.1M25.4%00.0%UnchangedHolders
Q4 2021638,800$42.2M17.3%00.0%UnchangedHolders
Q3 2021638,800$53.6M15.2%00.0%UnchangedHolders
Q2 2021638,800$81.1M22.3%00.0%UnchangedHolders
Q1 2021638,800$70.1M21.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.